Financials
- Market Capitalization 11.38 B
- Employee 3 000
- Founded 1976
- CEO Kim Kelderman
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
60.91
Rapporto prezzo/fatturato
9.13
Dividendi per azione
0.32
Rendimento da dividendi %
0.45
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 794 | CORT Corcept Therapeutics Incorporated - Common Stock | 110.16 USD | -2.83% | -9.11% | -5.68% | +50.14% | 11.91 B USD | ||
| 802 | SMMT Summit Therapeutics Inc. - Common Stock | 14.63 USD | -4.81% | -15.63% | -17.53% | -26.33% | 11.67 B USD | ||
| 854 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.68 USD | -2.44% | -0.58% | -16.20% | +2.49% | 10.58 B USD | ||
| 863 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 449.74 USD | -2.19% | -4.67% | -15.95% | +6.17% | 10.39 B USD |